These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34399146)

  • 41. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.
    Grünblatt E; Riederer P
    J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative MRI to understand Alzheimer's disease pathophysiology.
    Bozzali M; Serra L; Cercignani M
    Curr Opin Neurol; 2016 Aug; 29(4):437-44. PubMed ID: 27228309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and Prognostic Potential of Retinal Biomarkers in Early On-Set Alzheimer's Disease.
    Shariflou S; Georgevsky D; Mansour H; Rezaeian M; Hosseini N; Gani F; Gupta V; Braidy N; Golzan SM
    Curr Alzheimer Res; 2017; 14(9):1000-1007. PubMed ID: 28356048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.
    Blennow K; Biscetti L; Eusebi P; Parnetti L
    Mov Disord; 2016 Jun; 31(6):836-47. PubMed ID: 27145480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases.
    Murueta-Goyena A; Del Pino R; Reyero P; Galdós M; Arana B; Lucas-Jiménez O; Acera M; Tijero B; Ibarretxe-Bilbao N; Ojeda N; Peña J; Cortés J; Gómez-Esteban JC; Gabilondo I
    Mov Disord; 2019 Sep; 34(9):1315-1324. PubMed ID: 31136022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases.
    Braak H; de Vos RA; Jansen EN; Bratzke H; Braak E
    Prog Brain Res; 1998; 117():267-85. PubMed ID: 9932414
    [No Abstract]   [Full Text] [Related]  

  • 50. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-invasive optical imaging of retinal Aβ plaques using curcumin loaded polymeric micelles in APP
    Chibhabha F; Yang Y; Ying K; Jia F; Zhang Q; Ullah S; Liang Z; Xie M; Li F
    J Mater Chem B; 2020 Aug; 8(33):7438-7452. PubMed ID: 32662804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Shao Y; Jiang H; Wei Y; Shi Y; Shi C; Wright CB; Sun X; Vanner EA; Rodriguez AD; Lam BL; Rundek T; Baumel BS; Gameiro GR; Dong C; Wang J
    J Alzheimers Dis; 2018; 64(4):1261-1273. PubMed ID: 30040712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
    Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
    Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parkinson's disease in patients with Alzheimer's disease.
    Leverenz J; Sumi SM
    Arch Neurol; 1986 Jul; 43(7):662-4. PubMed ID: 3729742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycation in Parkinson's disease and Alzheimer's disease.
    Vicente Miranda H; El-Agnaf OM; Outeiro TF
    Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
    Normando EM; Davis BM; De Groef L; Nizari S; Turner LA; Ravindran N; Pahlitzsch M; Brenton J; Malaguarnera G; Guo L; Somavarapu S; Cordeiro MF
    Acta Neuropathol Commun; 2016 Aug; 4(1):86. PubMed ID: 27535749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease.
    Hadoux X; Hui F; Lim JKH; Masters CL; Pébay A; Chevalier S; Ha J; Loi S; Fowler CJ; Rowe C; Villemagne VL; Taylor EN; Fluke C; Soucy JP; Lesage F; Sylvestre JP; Rosa-Neto P; Mathotaarachchi S; Gauthier S; Nasreddine ZS; Arbour JD; Rhéaume MA; Beaulieu S; Dirani M; Nguyen CTO; Bui BV; Williamson R; Crowston JG; van Wijngaarden P
    Nat Commun; 2019 Sep; 10(1):4227. PubMed ID: 31530809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
    J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
    Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
    Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.